Targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to identify natural product inhibitors via structure-based computational approach

Abstract Cancer has been viewed as one of the deadliest diseases worldwide. Among various types of cancer, breast cancer is the most common type of cancer in women. Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is a promising druggable target and is overexpressed in cancerous cells, like, breas...

Full description

Bibliographic Details
Main Authors: Nisarg Rana, Dhaval Patel, Meet Parmar, Nandini Mukherjee, Prakash C. Jha, Anu Manhas
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-45175-3
_version_ 1797452724086767616
author Nisarg Rana
Dhaval Patel
Meet Parmar
Nandini Mukherjee
Prakash C. Jha
Anu Manhas
author_facet Nisarg Rana
Dhaval Patel
Meet Parmar
Nandini Mukherjee
Prakash C. Jha
Anu Manhas
author_sort Nisarg Rana
collection DOAJ
description Abstract Cancer has been viewed as one of the deadliest diseases worldwide. Among various types of cancer, breast cancer is the most common type of cancer in women. Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is a promising druggable target and is overexpressed in cancerous cells, like, breast cancer. We conducted structure-based modeling on the allosteric site of the enzyme. Targeting the allosteric site avoids the problem of drug resistance. Pharmacophore modeling, molecular docking, HYDE assessment, drug-likeness, ADMET predictions, simulations, and free-energy calculations were performed. The RMSD, RMSF, RoG, SASA, and Hydrogen-bonding studies showed that seven candidates displayed stable behaviour. As per the literature, average superimposed simulated structures revealed a similar protein conformational change in the αEʹ-βfʹ loop, causing its displacement away from the allosteric site. The MM-PBSA showed tight binding of six compounds with the allosteric pocket. The effect of inhibitors interacting in the allosteric site causes a decrease in the binding energy of J49 (active-site inhibitor), suggesting the effect of allosteric binding. The PCA and FEL analysis revealed the significance of the docked compounds in the stable behaviour of the complexes. The outcome can contribute to the development of potential natural products with drug-like properties that can inhibit the MTHFD2 enzyme.
first_indexed 2024-03-09T15:11:47Z
format Article
id doaj.art-75c1638ccbbc4faf9dc307937ff1f25c
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-09T15:11:47Z
publishDate 2023-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-75c1638ccbbc4faf9dc307937ff1f25c2023-11-26T13:18:32ZengNature PortfolioScientific Reports2045-23222023-10-0113112210.1038/s41598-023-45175-3Targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to identify natural product inhibitors via structure-based computational approachNisarg Rana0Dhaval Patel1Meet Parmar2Nandini Mukherjee3Prakash C. Jha4Anu Manhas5Department of Chemistry, School of Energy Technology, Pandit Deendayal Energy UniversityDepartment of Industrial Biotechnology, Gujarat Biotechnology UniversityDepartment of Industrial Biotechnology, Gujarat Biotechnology UniversityDepartment of Chemistry, School of Energy Technology, Pandit Deendayal Energy UniversitySchool of Applied Material Sciences, Central University of GujaratDepartment of Chemistry, School of Energy Technology, Pandit Deendayal Energy UniversityAbstract Cancer has been viewed as one of the deadliest diseases worldwide. Among various types of cancer, breast cancer is the most common type of cancer in women. Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is a promising druggable target and is overexpressed in cancerous cells, like, breast cancer. We conducted structure-based modeling on the allosteric site of the enzyme. Targeting the allosteric site avoids the problem of drug resistance. Pharmacophore modeling, molecular docking, HYDE assessment, drug-likeness, ADMET predictions, simulations, and free-energy calculations were performed. The RMSD, RMSF, RoG, SASA, and Hydrogen-bonding studies showed that seven candidates displayed stable behaviour. As per the literature, average superimposed simulated structures revealed a similar protein conformational change in the αEʹ-βfʹ loop, causing its displacement away from the allosteric site. The MM-PBSA showed tight binding of six compounds with the allosteric pocket. The effect of inhibitors interacting in the allosteric site causes a decrease in the binding energy of J49 (active-site inhibitor), suggesting the effect of allosteric binding. The PCA and FEL analysis revealed the significance of the docked compounds in the stable behaviour of the complexes. The outcome can contribute to the development of potential natural products with drug-like properties that can inhibit the MTHFD2 enzyme.https://doi.org/10.1038/s41598-023-45175-3
spellingShingle Nisarg Rana
Dhaval Patel
Meet Parmar
Nandini Mukherjee
Prakash C. Jha
Anu Manhas
Targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to identify natural product inhibitors via structure-based computational approach
Scientific Reports
title Targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to identify natural product inhibitors via structure-based computational approach
title_full Targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to identify natural product inhibitors via structure-based computational approach
title_fullStr Targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to identify natural product inhibitors via structure-based computational approach
title_full_unstemmed Targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to identify natural product inhibitors via structure-based computational approach
title_short Targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to identify natural product inhibitors via structure-based computational approach
title_sort targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 mthfd2 to identify natural product inhibitors via structure based computational approach
url https://doi.org/10.1038/s41598-023-45175-3
work_keys_str_mv AT nisargrana targetingallostericbindingsiteinmethylenetetrahydrofolatedehydrogenase2mthfd2toidentifynaturalproductinhibitorsviastructurebasedcomputationalapproach
AT dhavalpatel targetingallostericbindingsiteinmethylenetetrahydrofolatedehydrogenase2mthfd2toidentifynaturalproductinhibitorsviastructurebasedcomputationalapproach
AT meetparmar targetingallostericbindingsiteinmethylenetetrahydrofolatedehydrogenase2mthfd2toidentifynaturalproductinhibitorsviastructurebasedcomputationalapproach
AT nandinimukherjee targetingallostericbindingsiteinmethylenetetrahydrofolatedehydrogenase2mthfd2toidentifynaturalproductinhibitorsviastructurebasedcomputationalapproach
AT prakashcjha targetingallostericbindingsiteinmethylenetetrahydrofolatedehydrogenase2mthfd2toidentifynaturalproductinhibitorsviastructurebasedcomputationalapproach
AT anumanhas targetingallostericbindingsiteinmethylenetetrahydrofolatedehydrogenase2mthfd2toidentifynaturalproductinhibitorsviastructurebasedcomputationalapproach